000153861 001__ 153861
000153861 005__ 20240229123051.0
000153861 0247_ $$2doi$$a10.1016/S1470-2045(19)30856-3
000153861 0247_ $$2pmid$$apmid:32105622
000153861 0247_ $$2ISSN$$a1470-2045
000153861 0247_ $$2ISSN$$a1474-5488
000153861 0247_ $$2altmetric$$aaltmetric:76622809
000153861 037__ $$aDKFZ-2020-00479
000153861 041__ $$aeng
000153861 082__ $$a610
000153861 1001_ $$aHong, David S$$b0
000153861 245__ $$aLarotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
000153861 260__ $$aLondon$$bThe Lancet Publ. Group$$c2020
000153861 3367_ $$2DRIVER$$aarticle
000153861 3367_ $$2DataCite$$aOutput Types/Journal article
000153861 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1587034934_8817
000153861 3367_ $$2BibTeX$$aARTICLE
000153861 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153861 3367_ $$00$$2EndNote$$aJournal Article
000153861 500__ $$a2020 Apr;21(4):531-540
000153861 520__ $$aLarotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
000153861 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000153861 588__ $$aDataset connected to CrossRef, PubMed,
000153861 7001_ $$aDuBois, Steven G$$b1
000153861 7001_ $$aKummar, Shivaani$$b2
000153861 7001_ $$aFarago, Anna F$$b3
000153861 7001_ $$aAlbert, Catherine M$$b4
000153861 7001_ $$aRohrberg, Kristoffer S$$b5
000153861 7001_ $$0P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271$$avan Tilburg, Cornelis M$$b6$$udkfz
000153861 7001_ $$aNagasubramanian, Ramamoorthy$$b7
000153861 7001_ $$aBerlin, Jordan D$$b8
000153861 7001_ $$aFederman, Noah$$b9
000153861 7001_ $$aMascarenhas, Leo$$b10
000153861 7001_ $$aGeoerger, Birgit$$b11
000153861 7001_ $$aDowlati, Afshin$$b12
000153861 7001_ $$aPappo, Alberto S$$b13
000153861 7001_ $$aBielack, Stefan$$b14
000153861 7001_ $$aDoz, François$$b15
000153861 7001_ $$aMcDermott, Ray$$b16
000153861 7001_ $$aPatel, Jyoti D$$b17
000153861 7001_ $$aSchilder, Russell J$$b18
000153861 7001_ $$aTahara, Makoto$$b19
000153861 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan M$$b20$$udkfz
000153861 7001_ $$0P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aWitt, Olaf$$b21$$udkfz
000153861 7001_ $$aLadanyi, Marc$$b22
000153861 7001_ $$aRudzinski, Erin R$$b23
000153861 7001_ $$aNanda, Shivani$$b24
000153861 7001_ $$aChilds, Barrett H$$b25
000153861 7001_ $$aLaetsch, Theodore W$$b26
000153861 7001_ $$aHyman, David M$$b27
000153861 7001_ $$aDrilon, Alexander$$b28
000153861 773__ $$0PERI:(DE-600)2035574-9$$a10.1016/S1470-2045(19)30856-3$$gp. S1470204519308563$$n4$$p531-540$$tThe lancet <London> / Oncology Oncology$$v21$$x1470-2045$$y2020
000153861 909CO $$ooai:inrepo02.dkfz.de:153861$$pVDB
000153861 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a6b5fcabf661bef95109dbee87dc5271$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000153861 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b20$$kDKFZ
000153861 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aDeutsches Krebsforschungszentrum$$b21$$kDKFZ
000153861 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000153861 9141_ $$y2020
000153861 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153861 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153861 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000153861 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLANCET ONCOL : 2017
000153861 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000153861 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000153861 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153861 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153861 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153861 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000153861 915__ $$0StatID:(DE-HGF)9930$$2StatID$$aIF >= 30$$bLANCET ONCOL : 2017
000153861 9201_ $$0I:(DE-He78)B310-20160331$$kB310$$lKKE Pädiatrische Onkologie$$x0
000153861 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000153861 980__ $$ajournal
000153861 980__ $$aVDB
000153861 980__ $$aI:(DE-He78)B310-20160331
000153861 980__ $$aI:(DE-He78)B062-20160331
000153861 980__ $$aUNRESTRICTED